Form D · Other Health Care

BioWound Solutions, LLC

Las Vegas, NV · CIK 0002007142

Offering snapshot reported Feb 5, 2024 · SEC filing

Reported sold
$4.51M
Offering amount: $4.51M
Investors reported
7
Form D · investor count
Minimum accepted
$110K
Reported outside-investor minimum
First sale
Dec 26, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.26M$4.51MJan 5, 2024: $3,575,000.00Jan 5, 2024Feb 5, 2024: $4,510,000.00Feb 5, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,575,000 → $4,510,000
  • Reported investors2 → 7
  • Minimum accepted$275,000 → $110,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 5, 2024Amendment$4,510,000$935,000vs Jan 5, 20247SEC filing
Jan 5, 2024Initial$3,575,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-501740

Source: Form D, filed Feb 5, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Nicholas Andolino Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
8275 South Eastern Avenue #200
Las Vegas, NV, 89123